142 related articles for article (PubMed ID: 34274194)
1. Depletion of miR-155 hinders the myofibroblast activities and reactive oxygen species generation in oral submucous fibrosis.
Chou MY; Fang CY; Hsieh PL; Liao YW; Yu CC; Lee SS
J Formos Med Assoc; 2022 Feb; 121(2):467-472. PubMed ID: 34274194
[TBL] [Abstract][Full Text] [Related]
2. miR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesis.
Liu CM; Liao YW; Hsieh PL; Yu CH; Chueh PJ; Lin T; Yang PY; Yu CC; Chou MY
J Formos Med Assoc; 2019 Jul; 118(7):1093-1098. PubMed ID: 30928188
[TBL] [Abstract][Full Text] [Related]
3. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
[TBL] [Abstract][Full Text] [Related]
4. miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.
Fang CY; Yu CC; Liao YW; Hsieh PL; Ohiro Y; Chu PM; Huang YC; Yu CH; Tsai LL
J Formos Med Assoc; 2020 Jul; 119(7):1167-1173. PubMed ID: 32265096
[TBL] [Abstract][Full Text] [Related]
5. Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis.
Yu CC; Liao YW; Hsieh PL; Chang YC
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672311
[TBL] [Abstract][Full Text] [Related]
6. Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblasts.
Su JY; Yu CC; Peng CY; Liao YW; Hsieh PL; Yang LC; Yu CH; Chou MY
J Formos Med Assoc; 2021 Nov; 120(11):2010-2015. PubMed ID: 33965260
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-29c promotes the progression of oral submucous fibrosis through targeting tropomyosin-1.
Yang PY; Ho DC; Chen SH; Hsieh PL; Liao YW; Tsai LL; Yu CC; Fang CY
J Formos Med Assoc; 2022 Jun; 121(6):1117-1122. PubMed ID: 34696938
[TBL] [Abstract][Full Text] [Related]
8. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
9. Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.
Yang HW; Yu CC; Hsieh PL; Liao YW; Chu PM; Yu CH; Fang CY
J Formos Med Assoc; 2021 Apr; 120(4):1108-1113. PubMed ID: 33191095
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
Huang J; Zhang H; Fan X; Guo J
Oral Health Prev Dent; 2022 Jun; 20(1):339-348. PubMed ID: 35920886
[TBL] [Abstract][Full Text] [Related]
11. Aberrantly downregulated FENDRR by arecoline elevates ROS and myofibroblast activation via mitigating the miR-214/MFN2 axis.
Liao YW; Yu CC; Hsieh CW; Chao SC; Hsieh PL
Int J Biol Macromol; 2024 Apr; 264(Pt 1):130504. PubMed ID: 38442830
[TBL] [Abstract][Full Text] [Related]
12. LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis.
Lin CY; Liao YW; Hsieh PL; Lu MY; Peng CY; Chu PM; Yang HW; Huang YF; Yu CC; Yu CH
J Formos Med Assoc; 2018 Aug; 117(8):727-733. PubMed ID: 29249416
[TBL] [Abstract][Full Text] [Related]
13. Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis.
Su TR; Liao YW; Hsieh PL; Tsai LL; Fang CY; Lin T; Lee YH; Harn HJ; Yu CC
Environ Toxicol; 2018 Jun; 33(6):686-694. PubMed ID: 29665273
[TBL] [Abstract][Full Text] [Related]
14. miR-21 promotes the fibrotic properties in oral mucosa through targeting PDCD4.
Liao YW; Tsai LL; Lee YH; Hsieh PL; Yu CC; Lu MY
J Dent Sci; 2022 Apr; 17(2):677-682. PubMed ID: 35756803
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lncRNA HOTTIP ameliorated myofibroblast activities and inflammatory cytokines in oral submucous fibrosis.
Lee YH; Yu CC; Hsieh PL; Liao YW; Yu CH; Su TR
J Formos Med Assoc; 2021 May; 120(5):1188-1193. PubMed ID: 33504462
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression.
Chang YC; Lin CW; Yu CC; Wang BY; Huang YH; Hsieh YC; Kuo YL; Chang WW
Oncotarget; 2016 Mar; 7(11):12137-49. PubMed ID: 26934322
[TBL] [Abstract][Full Text] [Related]
17. Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition.
Lin CY; Hsieh PL; Liao YW; Peng CY; Yu CC; Lu MY
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884781
[TBL] [Abstract][Full Text] [Related]
18. Paeonol inhibits profibrotic signaling and HOTAIR expression in fibrotic buccal mucosal fibroblasts.
Ho DC; Chen SH; Fang CY; Hsieh CW; Hsieh PL; Liao YW; Yu CC; Tsai LL
J Formos Med Assoc; 2022 May; 121(5):930-935. PubMed ID: 34696937
[TBL] [Abstract][Full Text] [Related]
19. Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa.
Fang CY; Hsia SM; Hsieh PL; Liao YW; Peng CY; Wu CZ; Lin KC; Tsai LL; Yu CC
J Cell Physiol; 2019 May; 234(5):6721-6730. PubMed ID: 30230545
[TBL] [Abstract][Full Text] [Related]
20. XIST/let-7i/HMGA1 axis maintains myofibroblasts activities in oral submucous fibrosis.
Yu CH; Hsieh PL; Chao SC; Chen SH; Liao YW; Yu CC
Int J Biol Macromol; 2023 Mar; 232():123400. PubMed ID: 36702230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
